About
Starlight Cardiovascular is developing much needed tools and devices to treat pediatric Congenital Heart Defects (CHDs). Approximately 1.3 million babies are born each year with a CHD. Most of the tools used to treat these children were designed for adult conditions and anatomy, limiting their utility for pediatric patients. Starlight Cardiovascular is developing a portfolio of devices designed and tested specifically for pediatric CHD with the goals of improving morbidity, mortality, and access to care.
Technologies
Gmail
Google Apps
Mobile Friendly
Squarespace ECommerce
Remote
Keywords
neonatal stent development
chd access tools
pediatric catheterization devices
medical devices
healthcare equipment & supplies
consulting
small vessel treatment devices
device testing for children
pediatric cardiology tools
manufacturing
chd treatment devices
pediatric device innovation
pediatric cardiovascular devices
neonatal-sized stents
pediatric intervention devices
b2b
medical technology
neonatal circulatory system
medical equipment and supplies manufacturing
pediatric healthcare
medical device development
pediatric congenital heart disease
neonatal stent
healthcare technology
pediatric cardiology innovation
healthcare
hospital & health care
mechanical or industrial engineering
health care
health
Company Information
-
Employees 14
-
Founded 2020
-
Annual Revenue $500000
-
Total Funding $9480000
Location
9710 Scranton Rd, San Diego, California, United States, 92121-1711
